Cargando…

Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects

Empty virions are inadvertent by-products of recombinant adeno-associated virus (rAAV) packaging process, resulting in vector lots with mixtures of full and empty virions at variable ratios. Impact of empty virions on the efficiency and side effects of rAAV transduction has not been well characteriz...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Kai, Li, Mengxin, Zhong, Li, Su, Qin, Li, Jia, Li, Shaoyong, He, Ran, Zhang, Yu, Hendricks, Gregory, Wang, Junzhi, Gao, Guangping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255953/
https://www.ncbi.nlm.nih.gov/pubmed/25485285
http://dx.doi.org/10.1038/mtm.2013.9
_version_ 1782347516321202176
author Gao, Kai
Li, Mengxin
Zhong, Li
Su, Qin
Li, Jia
Li, Shaoyong
He, Ran
Zhang, Yu
Hendricks, Gregory
Wang, Junzhi
Gao, Guangping
author_facet Gao, Kai
Li, Mengxin
Zhong, Li
Su, Qin
Li, Jia
Li, Shaoyong
He, Ran
Zhang, Yu
Hendricks, Gregory
Wang, Junzhi
Gao, Guangping
author_sort Gao, Kai
collection PubMed
description Empty virions are inadvertent by-products of recombinant adeno-associated virus (rAAV) packaging process, resulting in vector lots with mixtures of full and empty virions at variable ratios. Impact of empty virions on the efficiency and side effects of rAAV transduction has not been well characterized. Here, we generated partially and completely empty AAV8 virions, fully packaged rAAV8 lots, and mixtures of empty and fully packaged virions with variable ratios of empty virions. The aforementioned dosing formulations of rAAV8 expressing either cellular (EGFP (enhanced green fluorescent protein) or nuclear-targeted (n) LacZ) or secreted (human α1-antitrypsin (hA1AT)) reporter genes were intravenously injected into two different mouse strains, followed by analyses of transgene expressions and serum alanine aminotransferase (ALT) levels at different time points. We found that addition of empty particles to the fixed doses of rAAV8 preparations repressed liver transduction up to 64% (serum hA1AT) and 44% (nLacZ) in C57BL/6 mice, respectively. The similar trend in inhibiting EGFP expression together with concurrent elevations of serum ALT levels were observed in the BALB/c mice, indicating that empty particles may also exacerbate side effects of rAAV8 EGFP transduction. Our results suggest that removal of empty particles from rAAV preparations may improve efficacy and safety of AAV in clinical applications.
format Online
Article
Text
id pubmed-4255953
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42559532014-12-04 Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects Gao, Kai Li, Mengxin Zhong, Li Su, Qin Li, Jia Li, Shaoyong He, Ran Zhang, Yu Hendricks, Gregory Wang, Junzhi Gao, Guangping Mol Ther Methods Clin Dev Article Empty virions are inadvertent by-products of recombinant adeno-associated virus (rAAV) packaging process, resulting in vector lots with mixtures of full and empty virions at variable ratios. Impact of empty virions on the efficiency and side effects of rAAV transduction has not been well characterized. Here, we generated partially and completely empty AAV8 virions, fully packaged rAAV8 lots, and mixtures of empty and fully packaged virions with variable ratios of empty virions. The aforementioned dosing formulations of rAAV8 expressing either cellular (EGFP (enhanced green fluorescent protein) or nuclear-targeted (n) LacZ) or secreted (human α1-antitrypsin (hA1AT)) reporter genes were intravenously injected into two different mouse strains, followed by analyses of transgene expressions and serum alanine aminotransferase (ALT) levels at different time points. We found that addition of empty particles to the fixed doses of rAAV8 preparations repressed liver transduction up to 64% (serum hA1AT) and 44% (nLacZ) in C57BL/6 mice, respectively. The similar trend in inhibiting EGFP expression together with concurrent elevations of serum ALT levels were observed in the BALB/c mice, indicating that empty particles may also exacerbate side effects of rAAV8 EGFP transduction. Our results suggest that removal of empty particles from rAAV preparations may improve efficacy and safety of AAV in clinical applications. Nature Publishing Group 2014-01-29 /pmc/articles/PMC4255953/ /pubmed/25485285 http://dx.doi.org/10.1038/mtm.2013.9 Text en Copyright © 2014 American Society of Gene & Cell Therapy http://creativecommons.org/licenses/by/3.0/ This work is licensed under a Creative Commons Attribution Upported 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/deed.en_US
spellingShingle Article
Gao, Kai
Li, Mengxin
Zhong, Li
Su, Qin
Li, Jia
Li, Shaoyong
He, Ran
Zhang, Yu
Hendricks, Gregory
Wang, Junzhi
Gao, Guangping
Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
title Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
title_full Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
title_fullStr Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
title_full_unstemmed Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
title_short Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
title_sort empty virions in aav8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255953/
https://www.ncbi.nlm.nih.gov/pubmed/25485285
http://dx.doi.org/10.1038/mtm.2013.9
work_keys_str_mv AT gaokai emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT limengxin emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT zhongli emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT suqin emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT lijia emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT lishaoyong emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT heran emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT zhangyu emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT hendricksgregory emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT wangjunzhi emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects
AT gaoguangping emptyvirionsinaav8vectorpreparationsreducetransductionefficiencyandmaycausetotalviralparticledoselimitingsideeffects